PET imaging reveals distinctive roles for different regional adipose tissue depots in systemic glucose metabolism in nonobese humans
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Excess amounts of abdominal subcutaneous (SAT) and visceral (VAT) adipose tissue (AT) are associated with insulin resistance, even in normal-weight subjects. In contrast, gluteal-femoral AT (GFAT) is hypothesized to offer protection against insulin resistance. Dynamic PET imaging studies were undertaken to examine the contributions of both metabolic activity and size (volume) of these depots in systemic glucose metabolism. Nonobese, healthy volunteers ( n = 15) underwent dynamic PET imaging uptake of [18 F]FDG at a steady-state (20 mU·m−2·min−1) insulin infusion. PET images of tissue [18 F]FDG activity were coregistered with MRI to derive K values for insulin-stimulated rates of fractional glucose uptake within tissue. Adipose tissue volume was calculated from DEXA and MRI. VAT had significantly higher rates of fractional glucose uptake per volume than SAT ( P < 0.05) or GFAT ( P < 0.01). K GFAT correlated positively ( r = 0.67, P < 0.01) with systemic insulin sensitivity [glucose disappearance rate (R d)] and negatively with insulin-suppressed FFA ( r = −0.71, P < 0.01). SAT ( r = −0.70, P < 0.01) and VAT mass ( r = −0.55, P < 0.05) correlated negatively with R d, but GFAT mass did not. We conclude that rates of fractional glucose uptake within GFAT and VAT are significantly and positively associated with systemic insulin sensitivity in nonobese subjects. Furthermore, whereas SAT and VAT amounts are confirmed to relate to systemic insulin resistance, GFAT amount is not associated with insulin resistance. These dynamic PET imaging studies indicate that both quantity and quality of specific AT depots have distinct roles in systemic insulin resistance and may help explain the metabolically obese but normal-weight phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354 · cited 1×
“In addition, studies in our laboratory have shown that subcutaneous thigh AT mass either did not associate with IR or is positively associated with higher systemic insulin sensitivity (1, 8, 11).”
BackgroundAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319 · cited 1×
“Percent GFAT mass negatively correlated with RBP4, a known protein secreted by AT that is elevated in IR and possibly contributes to IR (13, 46).”
BackgroundRegional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
Fatty acids, obesity, and insulin resistance: Time for a reevaluation
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896 · cited 1×
“(20) have advocated that increased AT mass does not necessarily lead to increased FFA.”
BackgroundGoodpaster, B. H., Thaete, F. L., & Kelley, D. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.4.885 · Cited by 707 · cited 2×
“In addition, studies in our laboratory have shown that subcutaneous thigh AT mass either did not associate with IR or is positively associated with higher systemic insulin sensitivity (1, 8, 11).”
BackgroundSelf-citationSubdivisions of subcutaneous abdominal adipose tissue and insulin resistance
Kelley, D. E., Thaete, F. L., Troost, F., Huwe, T., & Goodpaster, B. H. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.5.e941 · Cited by 538 · cited 1×
“In the last 30 years, imaging studies have revealed that visceral AT is uniquely and strongly associated with IR (21).”
BackgroundSelf-citationGender differences in regional fatty acid metabolism before and after meal ingestion.
Jensen, M. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118285 · Cited by 191
Cited by
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484
Metabolic Flexibility in Health and Disease
Goodpaster, B. H., & Sparks, L. M. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.015 · Cited by 995
“Skeletal muscle accounts for 60%–80% of the increase in glucose metabolism in response to insulin (Ng et al., 2012), and an enormous body of work supports a causal role for skeletal muscle insulin resistance in type 2 diabetes (DeFronzo and Tripathy, 2009; Petersen et al., 2007).”
Self-citationShort-term Cold Acclimation Recruits Brown Adipose Tissue in Obese Humans
Hanssen, M. J. W., van der Lans, A. A. J. J., Brans, B., Hoeks, J., Jardon, K. M. C., Schaart, G., Mottaghy, F. M., Schrauwen, P., & van Marken Lichtenbelt, W. D. (2016) · Diabetes · doi:10.2337/db15-1372 · Cited by 293
Dynamic whole-body PET imaging: principles, potentials and applications
Rahmim, A., Lodge, M. A., Karakatsanis, N. A., Panin, V. Y., Zhou, Y., McMillan, A., Cho, S., Zaidi, H., Casey, M. E., & Wahl, R. L. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4153-6 · Cited by 273
Pataky, M. W., Yu, C. S., Nie, Y., Arias, E. B., Singh, M., Mendias, C. L., Ploutz-Snyder, R. J., & Cartee, G. D. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00482.2018 · Cited by 26
“Skeletal muscle insulin resistance is an essential defect leading to type 2 diabetes, and skeletal muscle is responsible for 60–80% of insulin-mediated glucose disposal (17, 44), making muscle a preeminent target to combat insulin resistance.”
Background
Metadata
- Authors
- Ng, J. M., Azuma, K., Kelley, C., Pencek, R., Radikova, Z., Laymon, C., Price, J., Goodpaster, B. H., & Kelley, D. E.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2012-11-01
- Volume
- 303
- Issue
- 9
- Pages
- E1134-E1141
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2134108446
- Cited by
- 67
- References
- 16
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PET imaging reveals distinctive roles for different regional adipose tissue depots in systemic glucose metabolism in nonobese humans. https://app.cochat.ai/papers/10.1152/ajpendo.00282.2012
- The paper
- Ng, J. M., Azuma, K., Kelley, C., Pencek, R., Radikova, Z., Laymon, C., Price, J., Goodpaster, B. H., & Kelley, D. E. (2012). PET imaging reveals distinctive roles for different regional adipose tissue depots in systemic glucose metabolism in nonobese humans. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.00282.2012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.